Multiple Myeloma Awareness Month: When the Doctor Becomes the Caregiver

Read More

The Analysis Of Clonal Diversity And Therapy Responses Using STAT3 Mutations As A Molecular Marker In Large Granular Lymphocytic Leukemia

Rajala et al.
Haematologica
Papers
January 2015
Authors and Affiliates
Rajala HL1, Olson T2, Clemente MJ3, Lagström S4, Ellonen P4, Lundan T5, Hamm DE6, Zaman SA4, Lopez Marti JM4,Andersson EI1, Jerez A7, Porkka K1, Maciejewski JP3, Loughran TP2, Mustjoki S8. 1Hematology Research Unit, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland. 2University of Virginia Cancer Center, Charlottesville, VA, USA. 3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. 4Institute for Molecular Medicine (FIMM), University of Helsinki, Finland. 5Department of Clinical Chemistry and TYKSLAB, University of Turku and Turku University Central Hospital, Finland. 6Adaptive Biotechnologies Corp, Seattle, WA, USA. 7Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain. 8Hematology Research Unit, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland